[HTML][HTML] Recent advances in cytomegalovirus infection management in solid organ transplant recipients
PA Grossi, M Peghin - Current Opinion in Organ Transplantation, 2024 - journals.lww.com
Recent advances in cytomegalovirus infection management in s... : Current Opinion in Organ
Transplantation Recent advances in cytomegalovirus infection management in solid organ …
Transplantation Recent advances in cytomegalovirus infection management in solid organ …
Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword
R Bharti, DR Calabrese - Frontiers in Transplantation, 2024 - frontiersin.org
Up to 90% of the global population has been infected with cytomegalovirus (CMV), a
herpesvirus that remains latent for the lifetime of the host and drives immune dysregulation …
herpesvirus that remains latent for the lifetime of the host and drives immune dysregulation …
[HTML][HTML] Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent …
D Bertrand, C Laurent, M Lemoine, L Lebourg… - Microorganisms, 2024 - mdpi.com
Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a
poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS …
poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS …